Reported Reactions

Devices › Test, hiv detection

Device brand name · Hiv detection test

Elecsys HIV combi PT: medical device reports filed with FDA

226 reports name it, 2017–2026. Manufacturer given most often on reports: Roche Diagnostics. Product code MZF.

226
device reports naming the brand
0% of all MAUDE reports · about 25 a year
193
reports, 12 months to August 2026
5 in the 12 months before
99.6%
classified as malfunction
93.3% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 226 reports that name the brand "Elecsys HIV combi PT" (hiv detection test), received between July 2017 and August 2026; the manufacturer given most often on reports is Roche Diagnostics. Spellings of one product vary from report to report.

193 reports arrived in the 12 months to August 2026, up 3760% from 5 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (99.6%) and injury (0.4%); across all test, hiv detection reports (product code MZF) death is recorded in 0.1% and malfunction in 93.3%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are false positive result (68.1%), non reproducible results (15%) and incorrect, inadequate or imprecise result or readings (8.4%). FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

058115Sep 2021: 1Oct 2021: 0Nov 2021: 1Dec 2021: 02022Jan 2022: 0Feb 2022: 0Mar 2022: 1Apr 2022: 1May 2022: 1Jun 2022: 0Jul 2022: 0Aug 2022: 0Sep 2022: 0Oct 2022: 0Nov 2022: 0Dec 2022: 12023Jan 2023: 0Feb 2023: 0Mar 2023: 0Apr 2023: 0May 2023: 0Jun 2023: 0Jul 2023: 0Aug 2023: 0Sep 2023: 0Oct 2023: 0Nov 2023: 0Dec 2023: 02024Jan 2024: 0Feb 2024: 0Mar 2024: 0Apr 2024: 0May 2024: 0Jun 2024: 1Jul 2024: 0Aug 2024: 0Sep 2024: 1Oct 2024: 0Nov 2024: 1Dec 2024: 02025Jan 2025: 0Feb 2025: 0Mar 2025: 0Apr 2025: 0May 2025: 1Jun 2025: 0Jul 2025: 0Aug 2025: 2Sep 2025: 115Oct 2025: 7Nov 2025: 12Dec 2025: 112026Jan 2026: 2Feb 2026: 7Mar 2026: 6Apr 2026: 5May 2026: 6Jun 2026: 7Jul 2026: 7Aug 2026: 8

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0741482017: 720172018: 420182019: 420192020: 420202021: 420212022: 420222024: 320242025: 14820252026: 482026

Event type and report source

Event type, as classified on the report

Death0%0
Injury0.4%1
Malfunction99.6%225
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%226
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,206 reports carrying product code MZF. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
False positive result15468.1%67.4%
Non reproducible results3415%4.4%
Incorrect, inadequate or imprecise result or readings198.4%5.8%
False negative result156.6%15.3%
Incorrect measurementthe device measured wrongly20.9%0.2%
Output problem20.9%0.8%
Calibration problem10.4%0.1%
Device handling problem10.4%0.1%
Improper or incorrect procedure or method10.4%0.5%
Low test results10.4%2.3%
Mechanical problema mechanical problem10.4%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

In context

MeasureElecsys HIV combi PTProduct code MZFAll MAUDE reports
Reports2263,20626,136,888
Share of that pool—7%0%
Classified as death, per 1,000 reports019
Classified as injury0.4%3.8%36.2%
Classified as malfunction99.6%93.3%62.3%
Filed by the manufacturer100%99.4%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code MZF

BrandReportsLatest 12 monthsClassified as death
DETERMINE HIV-1/2 Ag/Ab COMBO 25T8015690%
Alere Determine Hiv 1/2 Ag/Ab Combo50000.2%
Elecsys HIV Duo3193000%
ARCHITECT HIV Ag/Ab Combo21440.5%
Prism Hiv O Plus17000%
Alere Determine Hiv-1/2 Ag/Ab Combo15600%
Architect Havab Igm Reagent33500%
Advia Centaur Xp1,15110%
Architect I2000sr Analyzer1,78500.1%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Elecsys HIV combi PT reports

How many FDA reports name Elecsys HIV combi PT?

226 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 193 in the latest 12 months.

What kinds of events are reported?

malfunction (99.6%) and injury (0.4%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

false positive result (68.1%), non reproducible results (15%), incorrect, inadequate or imprecise result or readings (8.4%), false negative result (6.6%) and incorrect measurement (0.9%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Elecsys HIV combi PT was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.